Most newly discharged patients who recently recovered from COVID-19 produce virus-specific antibodies and T cells, suggests a study published on May 3rd in the journal Immunity, but the responses of different patients are not all the same. While the 14 patients examined in the study showed wide-ranging immune responses, results from the 6 of them that were assessed at two weeks after discharge suggest that antibodies were maintained for at least that long. Additional results from the study indicate which parts of the virus are most effective at triggering these immune responses and should therefore be targeted by potential vaccines.
Recently recovered COVID-19 patients ... - Lung Conditions C...
Recently recovered COVID-19 patients produce varying virus-specific antibodies.
![2greys profile image](https://images.hu-production.be/avatars/a9ca17ff0998af8a344aa9e934606936_small@2x_100x100.jpg)
Written by
![2greys profile image](https://images.hu-production.be/avatars/a9ca17ff0998af8a344aa9e934606936_small@2x_100x100.jpg)
2greys
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
That is so complicated but all the knowledge gained hopefully will be pooled and taken into account when the vaccine is finally available Too much at stake to have competition between countries and drug companies
Not what you're looking for?
You may also like...
Cancer Patients Face High Mortality from COVID-19
Cancer Patients Face High Mortality from COVID-19. Largest Study of Cancer Patients with COVID-19...
Scientists detail early lung infection in COVID-19 patients.
A global team of researchers has for the first time described the pathology of early phase of lung...
Study finds over 80 percent of COVID-19 patients have vitamin D deficiency.
Vitamin D deficiency was more prevalent in men.
Over 80 percent of 200 COVID-19 patients in a...
Blood clotting a significant cause of death in patients with COVID-19.
A study led by clinician scientists at RCSI University of Medicine and Health Sciences has found...
Adequate levels of vitamin D reduces complications, death among COVID-19 patients.
Hospitalized COVID-19 patients who were vitamin D sufficient, with a blood level of...